A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity (vol 586, pg 572, 2020)

被引:6
|
作者
Yang, Jingyun [1 ,2 ]
Wang, Wei [1 ,2 ]
Chen, Zimin [1 ,2 ]
Lu, Shuaiyao [2 ,3 ]
Yang, Fanli [1 ,2 ]
Bi, Zhenfei [1 ,2 ]
Bao, Linlin [4 ]
Mo, Fei [1 ,2 ]
Li, Xue [1 ,2 ]
Huang, Yong [1 ,2 ]
Hong, Weiqi [1 ,2 ]
Yang, Yun [3 ]
Zhao, Yuan [3 ]
Ye, Fei [1 ,2 ]
Lin, Sheng [1 ,2 ]
Deng, Wei [4 ]
Chen, Hua [1 ,2 ]
Lei, Hong [1 ,2 ]
Zhang, Ziqi [1 ,2 ]
Luo, Min [1 ,2 ]
Gao, Hong [4 ]
Zheng, Yue [1 ,2 ]
Gong, Yanqiu [1 ,2 ]
Jiang, Xiaohua [1 ,2 ]
Xu, Yanfeng [4 ]
Lv, Qi [4 ]
Li, Dan [1 ,2 ]
Wang, Manni [1 ,2 ]
Li, Fengdi [4 ]
Wang, Shunyi [4 ]
Wang, Guanpeng [4 ]
Yu, Pin [4 ]
Qu, Yajin [4 ]
Yang, Li [1 ,2 ]
Deng, Hongxin [1 ,2 ]
Tong, Aiping [1 ,2 ]
Li, Jiong [1 ,2 ]
Wang, Zhenling [1 ,2 ]
Yang, Jinliang [1 ,2 ]
Shen, Guobo [1 ,2 ]
Zhao, Zhiwei [1 ,2 ]
Li, Yuhua
Luo, Jingwen [1 ,2 ]
Liu, Hongqi [3 ]
Yu, Wenhai [3 ]
Yang, Mengli [3 ]
Xu, Jingwen [3 ]
Wang, Junbin [3 ]
Li, Haiyan [3 ,5 ]
Wang, Haixuan [3 ]
机构
[1] Sichuan Univ, Lab Aging Res & Canc Drug Target, State Key Lab Biotherapy, Natl Clin Res Ctr Geriatr,West China Hosp, Chengdu, Peoples R China
[2] Sichuan Univ, Canc Ctr, Natl Clin Res Ctr Geriatr, West China Hosp, Chengdu, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Kunming Highlevel Biosafety Primate Res Ctr, Inst Med Biol, Kunming, Yunnan, Peoples R China
[4] Chinese Acad Med Sci & Comparat Med Ctr, Peking Union Med Coll, Key Lab Human Dis Comparat Med,Inst Lab Anim Sci, Chinese Minist Hlth,Beijing Key Lab Anim Models E, Beijing, Peoples R China
[5] Natl Inst Food & Drug Control NIFDC, Beijing, Peoples R China
[6] Sichuan Univ, Collaborat Innovat Ctr Biotherapy, Natl Chengdu Ctr Safety Evaluat Drugs, State Key Lab Biotherapy,West CHina Hosp, Chengdu, Peoples R China
[7] Sichuan Univ, West China Hosp, Canc Ctr, Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China
[8] Tongji Univ, Sch Chem Sci & Engn, Shanghai Key Lab Chem Assessment & Sustainabil, Shanghai, Peoples R China
[9] Peoples Liberat Army Gen Hosp, Med Ctr 5, Treatment & Res Ctr Infect Dis, Natl Clin Res Ctr Infect Dis, Beijing, Peoples R China
[10] Macau Univ Sci & Technol, Fac Med, Ctr Biomed & Innovat, Macau, Peoples R China
[11] Tsinghua Univ, Dept Comp Sci & Technol, Beijing, Peoples R China
[12] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Peoples R China
[13] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China
[14] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Inst Lab Med, Chengdu, Peoples R China
[15] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, State Key Lab Med Mol Biol, Beijing, Peoples R China
[16] Sichuan Univ, West China Hosp, Emergency Dept, State Key Lab Biotherapy, Chengdu, Peoples R China
关键词
D O I
10.1038/s41586-020-03108-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A Correction to this paper has been published: https://doi.org/10.1007/s00125-020-03108-4.
引用
收藏
页码:E23 / E23
页数:1
相关论文
共 50 条
  • [41] Pre-existing immunity to SARS-CoV-2: the knowns and unknowns (vol 52, pg 891, 2020)
    Sette, Alessandro
    Crotty, Shane
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (10) : 644 - 644
  • [42] Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants
    Lei, Hong
    Alu, Aqu
    Yang, Jingyun
    Ren, Wenyan
    He, Cai
    Lan, Tianxia
    He, Xuemei
    Yang, Li
    Li, Jiong
    Wang, Zhenling
    Song, Xiangrong
    Wang, Wei
    Lu, Guangwen
    Wei, Xiawei
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [43] Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants
    Hong Lei
    Aqu Alu
    Jingyun Yang
    Wenyan Ren
    Cai He
    Tianxia Lan
    Xuemei He
    Li Yang
    Jiong Li
    Zhenling Wang
    Xiangrong Song
    Wei Wang
    Guangwen Lu
    Xiawei Wei
    Signal Transduction and Targeted Therapy, 7
  • [44] An RBD-Based Diagnostic Method Useful for the Surveillance of Protective Immunity against SARS-CoV-2 in the Population
    Adriana Ayon-Nunez, Dolores
    Cervantes-Torres, Jacquelynne
    Cabello-Gutierrez, Carlos
    Rosales-Mendoza, Sergio
    Rios-Valencia, Diana
    Huerta, Leonor
    Bobes, Raul J.
    Cesar Carrero, Julio
    Segura-Velazquez, Rene
    Alma Fierro, Nora
    Hernandez, Marisela
    Zuniga-Ramos, Joaquin
    Gamba, Gerardo
    Cardenas, Graciela
    Frias-Jimenez, Emmanuel
    Alonso Herrera, Luis
    Fragoso, Gladis
    Sciutto, Edda
    Suarez-Guemes, Francisco
    Pedro Laclette, Juan
    DIAGNOSTICS, 2022, 12 (07)
  • [45] Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice
    Mabrouk, Moustafa T.
    Chiem, Kevin
    Rujas, Edurne
    Huang, Wei-Chiao
    Jahagirdar, Dushyant
    Quinn, Breandan
    Nair, Meera Surendran
    Nissly, Ruth H.
    Cavener, Victoria S.
    Boyle, Nina R.
    Sornberger, Ty A.
    Kuchipudi, Suresh, V
    Ortega, Joaquin
    Julien, Jean-Philippe
    Martinez-Sobrido, Luis
    Lovell, Jonathan
    SCIENCE ADVANCES, 2021, 7 (49)
  • [46] Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2
    Lei, Hong
    Alu, Aqu
    Yang, Jingyun
    He, Cai
    Hong, Weiqi
    Cheng, Zesheng
    Yang, Li
    Li, Jiong
    Wang, Zhenling
    Wang, Wei
    Lu, Guangwen
    Wei, Xiawei
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [47] Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2
    Hong Lei
    Aqu Alu
    Jingyun Yang
    Cai He
    Weiqi Hong
    Zesheng Cheng
    Li Yang
    Jiong Li
    Zhenling Wang
    Wei Wang
    Guangwen Lu
    Xiawei Wei
    Signal Transduction and Targeted Therapy, 5
  • [48] Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing (vol 586, pg 113, 2020)
    Riva, Laura
    Yuan, Shuofeng
    Yin, Xin
    Martin-Sancho, Laura
    Matsunaga, Naoko
    Pache, Lars
    Burgstaller-Muehlbacher, Sebastian
    De Jesus, Paul D.
    Teriete, Peter
    Hull, Mitchell V.
    Chang, Max W.
    Chan, Jasper Fuk-Woo
    Cao, Jianli
    Poon, Vincent Kwok-Man
    Herbert, Kristina M.
    Cheng, Kuoyuan
    Nguyen, Tu-Trinh H.
    Rubanov, Andrey
    Pu, Yuan
    Nguyen, Courtney
    Choi, Angela
    Rathnasinghe, Raveen
    Schotsaert, Michael
    Miorin, Lisa
    Dejosez, Marion
    Zwaka, Thomas P.
    Sit, Ko-Yung
    Martinez-Sobrido, Luis
    Liu, Wen-Chun
    White, Kris M.
    Chapman, Mackenzie E.
    Lendy, Emma K.
    Glynne, Richard J.
    Albrecht, Randy
    Ruppin, Eytan
    Mesecar, Andrew D.
    Johnson, Jeffrey R.
    Benner, Christopher
    Sun, Ren
    Schultz, Peter G.
    Su, Andrew I.
    Garcia-Sastre, Adolfo
    Chatterjee, Arnab K.
    Yuen, Kwok-Yung
    Chanda, Sumit K.
    NATURE, 2024, 631 (8019) : E3 - E3
  • [49] RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants
    Liang, Qingtai
    Wang, Yifeng
    Zhang, Shuyuan
    Sun, Jing
    Sun, Wenbo
    Li, Jizhou
    Liu, Yaping
    Li, Mingxi
    Cheng, Lin
    Jiang, Yuhang
    Wang, Ruoke
    Zhang, Rui
    Yang, Zihan
    Ren, Yifei
    Chen, Peng
    Gao, Peng
    Yan, Huayuan
    Zhang, Zheng
    Zhang, Qi
    Shi, Xuanling
    Wang, Jianbin
    Liu, Wanli
    Wang, Xinquan
    Ying, Bo
    Zhao, Jincun
    Qi, Hai
    Zhang, Linqi
    ISCIENCE, 2022, 25 (04)
  • [50] A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures (vol 586, pg 560, 2020)
    Dinnon, Kenneth H., III
    Leist, Sarah R.
    Schafer, Alexandra
    Edwards, Caitlin E.
    Martinez, David R.
    Montgomery, Stephanie A.
    West, Ande
    Yount, Boyd L., Jr.
    Hou, Yixuan J.
    Adams, Lily E.
    Gully, Kendra L.
    Brown, Ariane J.
    Huang, Emily
    Bryant, Matthew D.
    Choong, Ingrid C.
    Glenn, Jeffrey S.
    Gralinski, Lisa E.
    Sheahan, Timothy P.
    Baric, Ralph S.
    NATURE, 2021, 590 (7844) : E22 - E22